Related Experiment Videos
A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule
Scandinavian Journal of Immunology
|January 1, 1975
Summary
This study presents a new radioimmunoassay to detect immune complexes (IC) and heat-aggregated IgG (delta IgG) in patient blood. The assay utilizes solid-phase C1q protein and demonstrates high sensitivity for detecting these markers.
Area of Science:
- Immunology
- Biochemistry
- Assay Development
Background:
- Circulating immune complexes (IC) are implicated in various autoimmune diseases.
- Accurate detection of IC and related markers like heat-aggregated IgG (delta IgG) is crucial for diagnosis and monitoring.
- Existing methods may have limitations in sensitivity or practicality.
Purpose of the Study:
- To develop and validate a novel solid-phase radioimmunoassay for detecting circulating C1q-binding immune complexes (IC) and heat-aggregated IgG (delta IgG).
- To establish the sensitivity, stability, and utility of the developed assay for clinical applications.
Main Methods:
- Adsorption of purified human C1q protein onto polystyrene tubes to create a solid-phase.
- Incubation with samples containing IC or delta IgG, followed by detection using radiolabeled tracers.
- Optimization of binding conditions, including ionic strength (mu) and temperature.
- Assessment of assay stability under storage conditions.
- Evaluation of detection limits using competitive binding assays with [125I]delta IgG.
Main Results:
- The assay demonstrated effective binding of delta IgG and IC to solid-phase C1q, enhanced at low ionic strength.
- Heating C1q significantly reduced binding capacity, indicating the importance of native C1q structure.
- The assay showed good stability, retaining binding capacity after several weeks of refrigerated storage.
- Detection limits were established at 2-5 ng for delta IgG and <50 ng for IC.
- Preliminary testing on human sera confirmed the assay's potential for detecting IC in patient samples.
Conclusions:
- A robust and sensitive solid-phase radioimmunoassay for C1q-binding IC and delta IgG has been successfully developed.
- The assay exhibits favorable stability and sensitivity, making it suitable for clinical diagnostics.
- This assay offers a valuable tool for the detection of immune complexes in patient sera, aiding in the diagnosis of related diseases.